TXMD - TherapeuticsMD, Inc.
1.3827
-0.027 -1.974%
Share volume: 13,981
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.41
-0.03
-0.02%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-15-2023 | 08-14-2023 | 11-14-2023 | 03-29-2024 | 05-10-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | |
| Total revenue | 416.000 K | 437.000 K | 0.000 | 449.000 K | 313.000 K | 234.000 K | 547.000 K | 667.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 416.000 K | 437.000 K | 0.000 | 449.000 K | 313.000 K | 234.000 K | 547.000 K | 667.000 K | |
| 5.05% | -100.00% | inf% | -30.29% | -25.24% | 133.76% | 21.94% | |||
| Operating expenses | 3.056 M | 2.781 M | 1.590 M | 1.476 M | 1.322 M | 1.233 M | 1.310 M | 879.000 K | |
| Selling general and admin | 3.056 M | 2.781 M | 1.590 M | 1.476 M | 1.322 M | 1.233 M | 1.310 M | 879.000 K | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 3.083 M | 2.909 M | 1.773 M | 2.060 M | 1.455 M | 2.674 M | 1.406 M | 986.000 K | |
| -5.64% | -39.05% | 16.19% | -29.37% | 83.78% | -47.42% | -29.87% | |||
| Operating income | -2.667 M | -2.472 M | -1.773 M | -1.611 M | -1.142 M | -2.440 M | -859.000 K | -319.000 K | |
| Ebit | -2.667 M | -2.472 M | -1.773 M | -1.611 M | -809.000 K | -1.045 M | -564.000 K | 75.000 K | |
| Pretax income | -2.310 M | -2.414 M | -1.434 M | -1.584 M | -809.000 K | -1.050 M | -567.000 K | 83.000 K | |
| 4.50% | -40.60% | 10.46% | -48.93% | 29.79% | -46.00% | -114.64% | |||
| Income tax | 0.000 | 0.000 | 0.000 | -43.000 K | 0.000 | 0.000 | 0.000 | -31.000 K | |
| Net income basic | -3.603 M | -2.414 M | -3.378 M | -883.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| 33.00% | -39.93% | 73.86% | 100.00% | ||||||
| Net income | -3.603 M | -2.414 M | -3.378 M | -883.000 K | -734.000 K | -1.090 M | -609.000 K | 252.000 K | |
| 33.00% | -39.93% | 73.86% | 16.87% | -48.50% | 44.13% | 141.38% |
